S-23 vs YK-11

S-23 wins for raw androgen receptor potency, visual hardening, zero estrogen/water retention, and predictable results when run for late-stage cutting or contest prep. Sourcing is easier and it's better characterized in the community, with more predictable shutdown/manageable PCT.
YK-11 wins for unique mechanism: myostatin inhibition via follistatin upregulation that offers legitimate recomposition potential. It's the only SARM-like designer that targets both AR and myostatin. For advanced users seeking a truly different pathway, it's the standout; also, some find androgenic sides milder than S-23 per mg. But the sourcing risk (mislabeled/mispropped powder, underdosing) is much higher.

Pick S-23 if:

• You want maximal dryness and muscle definition for the last 6–8 weeks of a prep/cut.
• You need a SARM "finisher" with true androgenic hardness, but avoid injectable orals.
• Managing estrogen is a concern (no water retention or gyno risk on S-23).
• You want a compound with consistent results and a large user knowledge base.
• You're willing to commit to full PCT and understand the shutdown risk.

Pick YK-11 if:

• You're chasing additional lean mass via myostatin inhibition (follistatin upregulation) and want something outside classic SARMs.
• You want a recomp or aesthetic lean-gains compound to layer with low-test/masteron or other SARMs.
• You're experienced with PCT and comfortable managing more steroid-like lipid/liver risks.
• Milder (per mg) androgenic effects are desirable, but you still want visible hardening/recomp.
• You're able to source real YK-11 from a vendor who provides COA testing — no exceptions.